Topical Hesperidin and Rubia Cordifolia (Manjistha) in Cutaneous Barrier Support, Venous-Stressed Skin and Post-Laser Recovery [HESPERIDIN CREAM]: A Critical Narrative Review

Abstract

Background: Flavanones and botanical quinones exhibit distinct biological actions in the stratum corneum and viable skin compartments. This narrative review critically evaluates the scientific rationale for topically applied hesperidin combined with Rubia cordifolia (Manjistha) extract as a candidate formulation for cutaneous barrier maintenance, dermal support under chronic venous stress, and post-laser skin recovery.

Evidence scope: Oral flavonoid preparations, including micronised purified flavonoid fraction (MPFF), were excluded, restricting evidence to dermal, explant and cell-based topical exposure. In murine models, topical native hesperidin accelerated epidermal permeability-barrier repair, increased differentiation markers, stimulated lamellar-body secretion and mitigated age- and glucocorticoid-associated barrier defects. Cutaneous cell and tissue assays indicate antioxidant, photoprotective and matrix-protective activity, including modulation of selected matrix metalloproteinases (MMPs) and increased fibroblast migration; several of these findings derive from hesperetin or hesperidin methyl chalcone (HMC) rather than native hesperidin, which are not interchangeable. In human skin explants, topically applied HMC reduced local vessel dilation and interleukin-8 (IL-8) production. Preclinical studies of Rubia cordifolia and its constituent alizarin show complementary antioxidant, anti-inflammatory and barrier-restorative activity.

Translational boundaries and conclusions: No controlled trial of a finished hesperidin–Rubia cordifolia topical formulation was identified. The mechanisms align closely with the demands of intact skin under chronic venous hypertension and of laser-disrupted skin, establishing ingredient-level rationale that product-specific testing can now convert into efficacy data. Such a combination is therefore positioned as a candidate cutaneous-support formulation, complementary to rather than a replacement for treatment of deep venous reflux and standard post-procedure care. Product characterisation, dermal-penetration, irritation and sensitisation data and controlled clinical studies remain necessary.